Hence, obesity promotes tumor progression and immune dysfunction, in particular by PD-1 upregulation; and this phenomenon can be exploited to improve response to PD-1/PD-L1 inhibition. Here, CD274 is linked to obesity due to melanocortin 4 receptor deficiency.